🇺🇸 ACE Inhibitors and Diuretics in United States
35 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 35
Most-reported reactions
- Renal Failure — 8 reports (22.86%)
- Vomiting — 4 reports (11.43%)
- Arthralgia — 3 reports (8.57%)
- Back Pain — 3 reports (8.57%)
- Flank Pain — 3 reports (8.57%)
- Hypertension — 3 reports (8.57%)
- Nausea — 3 reports (8.57%)
- Renal Failure Acute — 3 reports (8.57%)
- Urine Output Decreased — 3 reports (8.57%)
- Blood Creatinine Increased — 2 reports (5.71%)
Other Cardiovascular approved in United States
Frequently asked questions
Is ACE Inhibitors and Diuretics approved in United States?
ACE Inhibitors and Diuretics does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for ACE Inhibitors and Diuretics in United States?
The University of Texas Health Science Center, Houston is the originator. The local marketing authorisation holder may differ — check the official source linked above.